Chronic hepatitis or Renal disorder
Conditions
Interventions
Transjugular biopsy using EUS-FNA needle biopsy device
Sponsors
Kato Naoya
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who scheduled for a transvenous liver biopsy or transvenous renal biopsy due to chronic liver disease with/without renal impairment 2) Child-Pugh score A or B 3) Age is 20 years or older (any gender) 4) Patients who have been fully informed of and have obtained the written consent of their own free will to participate in the study.
Exclusion criteria
Exclusion criteria: 1) The patient who has one of the following cardiac diseases a) Heart failure of NYHA class 3 or higher. b) Current symptomatic coronary artery disease or a history of myocardial infarction within 4 weeks prior to enrollment. 2) Serious and active infection (CTCAE version 4.0 Grade 3 or higher) 3) Pregnant or lactating women and those who may or will become pregnant (if pregnancy is suspected, a pregnancy test should be performed). 4) There is a possibility of compromising patient safety or difficulty in complying with the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of serious adverse events causally related to the biopsy | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of non-serious adverse events causally related to the biopsy Degree of pain Success rate Amount of tissue collected Diagnostic capability Procedure time, a needle length of EUS-FNA | — |
Contacts
Public ContactTakayuki Kondo
Chiba University Hospital
Outcome results
None listed